THURSDAY, June 12, 2025 (HealthDay News) — A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. infants. The U.S. Food and Drug Administration (FDA) has approved a monoclonal antibody called Enflonsia, the drugmaker Merck announced June 9. GivenContinue Reading

THURSDAY, June 12, 2025 (HealthDay News) — Most folks tap away at their smartphone for fun, communication or information. But such tapping may also help them track the progress of a rare degenerative brain disease, researchers say. Five simple smartphone-measured tests of movement control can provide quick and regular insightContinue Reading